Two Sigma Securities LLC Sells 3,854 Shares of Zoetis Inc. (NYSE:ZTS)

Two Sigma Securities LLC reduced its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 59.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,646 shares of the company's stock after selling 3,854 shares during the period. Two Sigma Securities LLC's holdings in Zoetis were worth $431,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Howard Capital Management Group LLC raised its position in shares of Zoetis by 0.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company's stock valued at $20,489,000 after purchasing an additional 883 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of Zoetis by 17.3% in the 3rd quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company's stock valued at $464,497,000 after purchasing an additional 351,372 shares in the last quarter. Diamant Asset Management Inc. grew its stake in Zoetis by 2.4% in the third quarter. Diamant Asset Management Inc. now owns 4,465 shares of the company's stock worth $872,000 after purchasing an additional 105 shares in the last quarter. World Investment Advisors LLC increased its holdings in Zoetis by 29.1% in the third quarter. World Investment Advisors LLC now owns 34,236 shares of the company's stock valued at $6,689,000 after buying an additional 7,709 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB lifted its holdings in Zoetis by 801.0% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 18,606 shares of the company's stock worth $3,635,000 after buying an additional 16,541 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Price Performance

Shares of NYSE ZTS traded up $1.22 during trading on Wednesday, hitting $156.65. The company had a trading volume of 2,926,140 shares, compared to its average volume of 2,489,611. Zoetis Inc. has a 52 week low of $139.70 and a 52 week high of $200.33. The company has a market cap of $69.89 billion, a P/E ratio of 28.64, a PEG ratio of 2.78 and a beta of 0.92. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The business's 50-day moving average is $158.81 and its 200 day moving average is $167.98.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.03. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The business had revenue of $2.32 billion during the quarter, compared to analyst estimates of $2.30 billion. Equities research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.28%. Zoetis's payout ratio is 36.56%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Stifel Nicolaus reduced their price objective on Zoetis from $180.00 to $165.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Barclays increased their price objective on shares of Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. Morgan Stanley cut their price target on Zoetis from $243.00 to $238.00 and set an "overweight" rating on the stock in a report on Friday, February 14th. Piper Sandler increased their target price on Zoetis from $200.00 to $205.00 and gave the stock an "overweight" rating in a research report on Thursday, February 27th. Finally, StockNews.com raised shares of Zoetis from a "hold" rating to a "buy" rating in a report on Friday, March 7th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Zoetis has an average rating of "Buy" and an average price target of $214.40.

Insider Activity at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the sale, the executive vice president now owns 15,781 shares of the company's stock, valued at $2,682,770. This represents a 2.02 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Willie M. Reed sold 1,210 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total transaction of $201,029.40. Following the completion of the sale, the director now directly owns 11,245 shares of the company's stock, valued at approximately $1,868,244.30. This represents a 9.71 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,862 shares of company stock worth $312,254. 0.16% of the stock is owned by corporate insiders.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.